Joined: 12/6/2011
Posts: 3326
|
From Alzheimer's Daily News:
(Source: BuinessWeek) - Today scientists will give pharmaceutical investors long-awaited updates on research behind potential Alzheimer's disease treatments. Data from late-stage studies on solanezumab and bapineuzumab will be presented at a meeting of the American Neurological Association.
Initial study data on both drugs showed that they failed to slow mental decline, but researchers see some potential in them for possibly helping patients with early stages of Alzheimer's. Analysts and researchers have cautioned that this potential is remote, and more expensive clinical studies may be necessary.
Go to full story:
http://www.businessweek.com
|
Joined: 12/12/2011
Posts: 5158
|
Here is a little more information about the results from previous studies and the prospects for solanezumab.
http://www.forbes.com/sites/matthewherper/2012/10/08/an-alzheimers-hope-hanging-by-a-thread/
|